Antibody Therapeutics for Life

Notices

Dr. Jin-San Yoo, CEO of PharmAbcine is invited to present PharmAbcine`s R&D progress at the immuno oncology session at PHAR-EAST conference on March 1-2, 2018.
  • Written by Admin
  • Written date 2019-01-14 11:30:47
  • Inquire 1640

Dr. Jin-San Yoo, CEO of PharmAbcine is invited to present PharmAbcine`s R&D progress at the immuno oncology session at PHAR-EAST conference 

on March 1-2, 2018.

 

http://s3078.t.en25.com/e/es?s=3078&e=1868524&elq=b43a4d50c229484791e9c1fad25c81ef&elqaid=107201&elqat=1&elqTrackId=3be7a58a07da4d2f8b43cb1077043957

List





Prev Dr. Jin-San Yoo, CEO of PharmAbcine is attending and partnering at AusBiotech 20...
Next PharmAbcine Announces Presentation at the 2017 Annual Meeting of the Society of ...